Gene therapy avenues and COVID-19 vaccines

2020 has witnessed unprecedented situations due to coronavirus pandemic that affected all aspects of life. The whole globe lived months of uncertainty before two companies have announced the incredible results of phase III clinical trials for two different mRNA-based vaccines.

Detalles Bibliográficos
Autor principal: Abu Abed, Omar S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170448/
https://www.ncbi.nlm.nih.gov/pubmed/34079091
http://dx.doi.org/10.1038/s41435-021-00136-6
Descripción
Sumario:2020 has witnessed unprecedented situations due to coronavirus pandemic that affected all aspects of life. The whole globe lived months of uncertainty before two companies have announced the incredible results of phase III clinical trials for two different mRNA-based vaccines.

Ejemplares similares